Program Book

Name

Disclosure Entity

Disclosure Type

Presentation Number

Hassaine, Gherici

Theranyx

Employment (full or part-time) in funding company 1710-Pos Employment (full or part-time) in funding company 1033-Pos

Heedy, Sara

Anasys Instruments Corp.

Heerklotz, Heiko

this study was supported by an industry grant from AgraQuest/ Bayer CropScience

Research funded by industry grant

1497-Pos

Heifetz, Alexander Helmes, Michiel Hirakawa, Ryoko

Evotec (UK) Ltd Ionoptix LLC Gilead Sciences

Employment (full or part-time) in funding company 90-Plat Ownership or Partnership in funding organization 2849-Pos Employment (full or part-time) in funding company 1656-Pos

Hoang Trong, Minh Tuan NVIDIA

Research funded by industry grant Research funded by industry grant

2179-Plat

Hong, Jingjun

National Cancer Institute grant Y1-CO-1020, National Institute of General Medical Sciences grant Y1-GM-1104, and U.S. Depart- ment of Energy grant DE-AC02- 06CH11357 (APS).

249-Pos

Hu, Erding Hu, Qichi

GlaxoSmithKline

Employment (full or part-time) in funding company 3267-Plat Employment (full or part-time) in funding company 1033-Pos

Anasys Instruments Corp.

Hwang, You Jin

National Research Foundation of Korea(NRF)

Research funded by industry grant

3713-Pos

Jacobs, Donald J. Jafri, Mohsin S. January, Craig T.

Medimmune LLC

Research funded by industry grant Research funded by industry grant

3292-Pos 2179-Plat 2799-Pos

NVIDIA

Cofounder of Cellular Dynamics International

Other

Jesorka, Aldo

Co-founder of Avalance Biotech AB Stock options or bond holdings in a for-profit corporation or self-directed pension plan

1055-Pos

Jiang, Yong Jiang, Xin

GlaxoSmithKline

Employment (full or part-time) in funding company 3267-Plat Employment (full or part-time) in funding company 681-Pos

Molecular Devices, LLC

Jyothikumar, Vinod

National Heart, Lung, and Blood Institute (PO1HL101871) cofounder of Cellular Dynamics International

Other

3052-Pos

Kamp, Timothy J.

Other

2799-Pos

Kan, Elaine

Gilead Sciences

Stock options or bond holdings in a for-profit corporation or self-directed pension plan

2377-Pos

Kan, Elaine

Gilead Sciences Inc.

Employment (full or part-time) in funding company 1330-Pos

Karagueuzian, Hrayr S.

Gilead Sciences Inc., Foster City, California

Research funded by industry grant

3188-Plat

Kasson, Peter Kawas, Raja

Google, Inc

Employment (full or part-time) in funding company 3218-Symp Employment (full or part-time) in funding company 2842-Pos Employment (full or part-time) in funding company 694-Pos

MyoKardia, Inc.

Kettenhofen, Ralf Khalid, Syma Kjoller, Kevin Knapp, Stefan Kondo, Richard Kossolov, Eugen

Axiogenesis

Oxford Nanopore Technologies

Research funded by industry grant

2227-Plat

Anasys Instruments Corp.

Employment (full or part-time) in funding company 1033-Pos

Structural Genomics Consortium Research funded by industry grant

108-Plat

Sophion Bioscience

Employment (full or part-time) in funding company 3861-Pos Employment (full or part-time) in funding company 694-Pos Employment (full or part-time) in funding company 1500-Pos Employment (full or part-time) in funding company 1330-Pos Employment (full or part-time) in funding company 90-Plat

Axiogenesis

Lacey, Ernest

BioAustralis Pty Ltd Gilead Sciences Inc.

Lagpacan, Leanna

Law, Richard, J.

Evotec (UK) Ltd

293

Biophysical Society 58 th Annual Meeting, San Francisco, California

Made with